How can you advise patients taking ruxolitinib for vitiligo on looking for signs of repigmentation

Featuring Benjamin Lockshin, MD |

EVP of Strategic Initiatives
Director of the Clinical Trials Center
Assistant Professor
US Dermatology Partners
Georgetown University
Rockville, MD

| Published July 01, 2024